Pediatric Drugs

Papers
(The median citation count of Pediatric Drugs is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Alirocumab: Pediatric First Approval79
Safety of Ferric Carboxymaltose in Children: Report of a Case Series from Greece and Review of the Literature56
Diagnosis of Serious Conditions Delayed in Association with Ondansetron Treatment for Vomiting in the Pediatric Emergency Department42
Pharmacogenetic Aspects of Drug Metabolizing Enzymes and Transporters in Pediatric Medicine: Study Progress, Clinical Practice and Future Perspectives37
Treatment Options for Alopecia Areata in Children and Adolescents34
Managing Lupus Nephritis in Children and Adolescents33
Gentamicin Pharmacokinetics in Neonates Undergoing Therapeutic Hypothermia for Hypoxic Ischemic Encephalopathy32
Optimizing Drug Selection in Children with Multiple Sclerosis: What Do We Know and What Remains Unanswered?30
Efficacy of Secukinumab Across Subgroups and Overall Safety in Pediatric Patients with Moderate to Severe Plaque Psoriasis: Week 52 Results from a Phase III Randomized Study26
Perioperative Indications for Gabapentinoids in Pediatrics: A Narrative Review26
Acknowledgement to Referees25
Intranasal Analgesia in Preterm and Term Neonates25
Commercial Versus Compounded Preparations in Pediatric Ophthalmology22
A New Perspective on Drugs for Duchenne Muscular Dystrophy: Proposals for Better Respiratory Outcomes and Improved Regulatory Pathways21
Prevalence and Temporal Trends of Attention Deficit Hyperactivity Disorder Medication Fills During Pregnancy and Breastfeeding in Denmark21
New Information on Old Medicinal Products: A Cross-Sectional Analysis of Guidance for Paediatric Use for Substances on the European Priority List of Off-Patent Medicinal Products19
Low-Dose Remifentanil in Preterm Cesarean Section with General Anesthesia: A Randomized Controlled Trial18
Analysis of Risk Factors for Chloral Hydrate Sedative Failure with Initial Dose in Pediatric Patients: a Retrospective Analysis17
Management of Drug-Induced Epidermal Necrolysis (DEN) in Pediatric Patients: Moving from Drug-Induced Stevens–Johnson Syndrome, Overlap and Toxic Epidermal Necrolysis to a Single Unifying Diagnosis of16
Improving Methylphenidate Titration in Children with Attention-Deficit/Hyperactivity Disorder (ADHD): A Randomized Controlled Trial Using Placebo-Controlled Titration Implemented in Clinical Practice16
Ewing Sarcoma Drug Therapy: Current Standard of Care and Emerging Agents15
Subgroup Analysis of Crisaborole for Mild-to-Moderate Atopic Dermatitis in Children Aged 2 to < 18 Years15
Real-World Data on the Use of Sirolimus in Asian Children with Vascular Malformations15
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management15
Letermovir for Prophylaxis and Pre-emptive Therapy of Cytomegalovirus Infection in Paediatric Allogeneic Haematopoietic Cell Transplant Patients14
Pharmacokinetics and Safety of Endotracheal Lidocaine for Endotracheal Intubation in Critically Ill Children14
Recent Developments in the Treatment of Pediatric Distal Renal Tubular Acidosis14
Inotuzumab Ozogamicin: First Pediatric Approval13
Dose Rationale of Nasal Glucagon in Japanese Pediatric Patients with Diabetes Using Pharmacokinetic/Pharmacodynamic Modeling and Simulation13
Learning-Based Models for Predicting IVIG Resistance and Coronary Artery Lesions in Kawasaki Disease: A Review of Technical Aspects and Study Features13
Pediatric Treatment-Resistant Obsessive Compulsive Disorder: Treatment Options and Challenges13
Diagnosis and Management of Non-Infectious Uveitis in Pediatric Patients13
Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children: Rationale and Progress to Date12
Immunotherapies for Pediatric Solid Tumors: A Targeted Update12
Oral Ibuprofen for the Treatment of PDA in Preterm Neonates: Urgent Need for a Safer Alternative to Hyperosmolar Formulations12
Population Pharmacokinetics and Dose Optimization of Piperacillin in Infants and Children with Pneumonia11
An Update of Pharmacological Management in Children with Functional Constipation11
Adverse Event Profile of First-line Drugs for Treating Patent Ductus Arteriosus in Neonates: A Disproportionality Analysis Study of USFDA Adverse Event Reporting System11
Off-Label Use of Anakinra in Inflammatory Conditions in Neonates and Infants Up to 3 Months of Age: A Case Series and a Review of the Literature10
Correction to: Secukinumab: A Review in Moderate to Severe Pediatric Plaque Psoriasis10
Emerging Treatments in Neonatal Fungal Infections: Progress and Prospects10
Targeted Treatments for Myasthenia Gravis in Children and Adolescents10
Comparison of Deep and Moderate Neuromuscular Blockade for Major Laparoscopic Surgery in Children: A Randomized Controlled Trial10
Best Evidence-Based Dosing Recommendations for Dexmedetomidine for Premedication and Procedural Sedation in Pediatrics: Outcome of a Risk-Benefit Analysis By the Dutch Pediatric Formulary10
Treatment of Langerhans Cell Histiocytosis and Histiocytic Disorders: A Focus on MAPK Pathway Inhibitors10
Medical Management of Infantile Hemangiomas: An Update9
Effectiveness and Safety of Ustekinumab in Pediatric Ulcerative Colitis: A Multi-center Retrospective Study from the Pediatric IBD Porto Group of ESPGHAN9
Insulin Glargine 300 U/mL Therapy in Children and Adolescents with Type 1 Diabetes9
Emerging Treatments for Childhood Interstitial Lung Disease9
Mechanistic Links Between Obesity and Airway Pathobiology Inform Therapies for Obesity-Related Asthma9
An Update on the Management of Childhood-Onset Systemic Lupus Erythematosus9
Toxicity Spectrum of Anti-GD2 Immunotherapy: A Real-World Study Leveraging the US Food and Drug Administration Adverse Event Reporting System9
The Effect of Alfentanil on Emergence Delirium Following General Anesthesia in Children: A Randomized Clinical Trial8
Acute Tolerability of Methylphenidate in Treatment-Naïve Children with ADHD: An Analysis of Naturalistically Collected Data from Clinical Practice8
Prescription Trends for Primary Headache in Children and Adolescents in China During 2019–2023: A Retrospective Study8
Current and Emerging Therapies for Prevention and Treatment of Bronchopulmonary Dysplasia in Preterm Infants8
Efficacy and Safety of Vamorolone in Duchenne Muscular Dystrophy: A Systematic Review8
Safety and Efficacy of Ledipasvir/Sofosbuvir in the Treatment of Chronic Hepatitis C Virus Infection in Treatment-Naïve Children without and with Comorbidities8
Neuroimaging as a Tool for Advancing Pediatric Psychopharmacology8
Dual-Targeted Therapy in Pediatric Inflammatory Bowel Disease: A Comprehensive Review8
Adverse Drug Reactions in Children with Congenital Heart Disease: A Scoping Review8
Prevalence and Perinatal Outcomes Following In Utero Exposure to Prehospital Emergency Methoxyflurane: A 17-Year Retrospective Cohort Study7
Treatment Options for Juvenile Pityriasis Rubra Pilaris7
Personalized Dosing of Medicines for Children: A Primer on Pediatric Pharmacometrics for Clinicians7
Executive Function Outcome of Treatment with Viloxazine Extended-Release Capsules in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Post-Hoc Analysis of Four Randomized Clin7
Dabigatran Etexilate: A Review in Pediatric Venous Thromboembolism7
Macitentan in the Young—Mid-term Outcomes of Patients with Pulmonary Hypertensive Vascular Disease treated in a Pediatric Tertiary Care Center7
Comparison of Different Doses of Oral and Ocular Propranolol for Retinopathy of Prematurity: A Network Meta-Analysis7
Phentermine/Topiramate: Pediatric First Approval7
Assessment of the Effects of a High Amikacin Dose on Plasma Peak Concentration in Critically Ill Children7
Optimising Paediatric HIV Treatment: Recent Developments and Future Directions7
Topical Management of Pediatric Psoriasis: A Review of New Developments and Existing Therapies6
Use of Furosemide and Chlorothiazide Combination Continuous Infusion in Furosemide-Refractory Patients in the Pediatric Intensive Care Unit: A Retrospective Cohort Study6
Real-Life Use of Biosimilars in Pediatric Inflammatory Bowel Disease: A Nation-Wide Web Survey on Behalf of the SIGENP IBD Working Group6
Developing CAR T-Cell Therapies for Pediatric Solid Tumors6
Diagnosis and Management of Pediatric Chronic Hand Eczema: The PeDRA CACHES Survey6
A Multi-Center Evaluation of the Pharmacokinetics and Safety of Intravenous Ibuprofen in Infants 1–6 Months of Age6
Macitentan: Pediatric First Approval6
Cardioprotective Effect of Nigella sativa in Pediatric Patients with Type 1 Diabetes Mellitus: A Randomized Controlled Study6
Drug Treatment of Heart Failure in Children: Gaps and Opportunities6
Diagnosis and Management of Pediatric Neuropsychiatric Systemic Lupus Erythematosus: An Update6
What Role for Long-Acting Injectable Antipsychotics in Managing Schizophrenia Spectrum Disorders in Children and Adolescents? A Systematic Review6
Juvenile Dermatomyositis: Updates in Pathogenesis and Biomarkers, Current Treatment, and Emerging Targeted Therapies5
Paediatric Drug Development in China: Current Status and Future Prospects5
Secukinumab: A Review in Moderate to Severe Pediatric Plaque Psoriasis5
Treatment Options in Pediatric Behçet’s Disease5
Efficacy and Safety of Proactive Therapy with 2% Crisaborole Ointment in Children with Mild-to-Moderate Atopic Dermatitis: A Randomized Controlled Study5
Management of Hospitalized Respiratory Syncytial Virus Bronchiolitis in the Pediatric Ward in Spain: Assessing the Impact of a New Clinical Practice Protocol5
Drug Treatment of Low Bone Mass and Other Bone Conditions in Pediatric Patients5
A Retrospective Review of Baclofen Treatment for Children with Rumination Syndrome at a Single Center5
Correction to: Viloxazine: Pediatric First Approval5
Ganaxolone: A Review in Epileptic Seizures Associated with Cyclin-Dependent Kinase-Like 5 Deficiency Disorder5
Enteral and Parenteral Treatment with Caffeine for Preterm Infants in the Delivery Room: A Randomised Trial4
Efficacy and Safety of the Adjuvant Use of Probiotic Bacillus clausii Strains in Pediatric Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study4
Acknowledgement to Referees4
A Review of Histamine-2 Receptor Antagonist and Proton Pump Inhibitor Therapy for Gastroesophageal Reflux Disease in Neonates and Infants4
Therapeutic Drug Monitoring of Antimicrobial Drugs in Children with Cancer: A New Tool for Personalized Medicine4
Pharmacokinetics of Ceftazidime in Children and Adolescents with Obesity4
Impact of Dexmedetomidine Infusion on Opioid and Benzodiazepine Doses in Ventilated Pediatric Patients in the Cardiac Intensive Care Unit4
Deferred Consent in Neonatal Clinical Research: Why, When, How?4
Ceftazidime/Avibactam for the Treatment of Infections in Children: A Case Series of Real-World Use4
The Future of Advanced Therapies for Pediatric Crohn’s Disease4
Deferred Consent in Pediatric Drug Trials: Moving from Why to How4
Antiretroviral Options and Treatment Decisions During Pregnancy4
Intravenous Golimumab in Patients with Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis and Subcutaneous Ustekinumab in Patients with Juvenile Psoriatic Arthritis: Extrapol4
Therapeutic Drug Monitoring of Voriconazole in Critically Ill Pediatric Patients: A Single-Center Retrospective Study4
Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant Bacteria4
Clinical Evidence Supporting FDA Approval of Gene and RNA Therapies for Rare Inherited Conditions3
Pharmacotherapy of Disruptive Behaviors in Children with Intellectual Disabilities3
Ibrutinib: Pediatric First Approval3
Population Pharmacokinetics of Adalimumab in Juvenile Idiopathic Arthritis Patients: A Retrospective Cohort Study Using Clinical Care Data3
Azacitidine (Vidaza®) in Pediatric Patients with Relapsed Advanced MDS and JMML: Results of a Phase I/II Study by the ITCC Consortium and the EWOG-MDS Group (Study ITCC-015)3
Pharmacokinetics of l-Citrulline in Neonates at Risk of Developing Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension3
Hemodynamic Quality Improvement Bundle to Reduce the Use of Inotropes in Extreme Preterm Neonates3
Asparaginase-Associated Pancreatitis in Pediatric Patients with Acute Lymphoblastic Leukemia: Current Perspectives3
Golimumab in Children with Chronic Recurrent Multifocal Osteomyelitis: A Case Series and Review of the Literature3
Navigating the Regulatory Landscape to Develop Pediatric Oncology Drugs: Expert Opinion Recommendations3
Antibiotics for Paediatric Community-Acquired Pneumonia: What is the Optimal Course Duration?3
Pharmacotherapy for Cancer Treatment-Related Cardiac Dysfunction and Heart Failure in Childhood Cancer Survivors3
A Narrative Review of Pain in Pediatric Oncology: The Opioid Option for Procedural and Surgical Pain3
Safety of Quinolones in Children: A Systematic Review and Meta-Analysis3
Correction to: Multidisciplinary Clinical Care in the Management of Patients Receiving Anti‑GD2 Immunotherapy for High‑Risk Neuroblastoma3
Impact of Antiseizure Medications on Appetite and Weight in Children3
Machine Learning: A Potential Therapeutic Tool to Facilitate Neonatal Therapeutic Decision Making3
How Consistent are Anti-Infective Drug Dosing Recommendations Across Three European Paediatric Formularies?3
Medication and Fluid Management of Pediatric Sepsis and Septic Shock3
Pediatric Drugs, Accelerated Approval, and Prospects for Reform3
Pharmacokinetics in Critically Ill Children with Acute Kidney Injury3
The Role of Pharmacotherapeutic Agents in Children with Desmoid Tumors3
0.27953600883484